Revolution Medicines Inc (NASDAQ:RVMD)

Delayed Data
As of Jan 27
 -1.68 / -7.76%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Revolution Medicines Inc have a median target of 37.00, with a high estimate of 38.00 and a low estimate of 31.00. The median estimate represents a +85.19% increase from the last price of 19.98.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Revolution Medicines Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 11.31%
Growthannually -24.52%


Growthquarterly 716.48%
Growthannually -33.03%
Key to the earnings and sales forecast charts.